Chopra Manjeet, Kumar Hemant
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Ahmedabad, Opposite Air Force Station, Palaj, Gandhinagar, Gujarat 382355, India.
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Ahmedabad, Opposite Air Force Station, Palaj, Gandhinagar, Gujarat 382355, India.
Drug Discov Today. 2025 Jun;30(6):104387. doi: 10.1016/j.drudis.2025.104387. Epub 2025 May 26.
Spinal cord injury (SCI) is a debilitating neurological condition characterized by sensory and motor deficits. It significantly affects patient quality of life and poses a substantial socioeconomic burden. The complex and multifaceted pathophysiology of SCI complicates its effective treatment. Following the primary mechanical insult, a secondary injury cascade disrupts the microenvironment at the injury site, exacerbating the tissue damage. Despite extensive research, no fully effective treatment is currently available. This review explores current pharmacological and non-pharmacological treatment strategies at the preclinical and clinical stages, providing insights into promising interventions. The findings highlight potential avenues for future research aimed at improving SCI management.